Tempus AI Expands Strategic Partnership Amid Oncology Boom [Yahoo! Finance]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Yahoo! Finance
designed for comprehensive genomic profiling of hematologic cancers and measurable residual disease monitoring. By integrating WGS with flow cytometry, the assay delivers highly sensitive and detailed cancer genome analysis. According to Nova One Advisor, the global oncology market is witnessing steady growth, driven by rising cancer incidences linked to increased alcohol and tobacco consumption. The growing demand for advanced diagnostics and treatments, along with awareness initiatives by governments and non-profit organizations, continues to support market expansion. The market is projected to reach approximately $483.45 billion by 2035, growing at a CAGR of 7.11% from 2026 to 2035. Reflecting this trend, Tempus AI has extended its multi-year partnership with Gilead Sciences GILD to advance oncology R&D. The collaboration leverages Tempus' multimodal data and AI-powered Lens platform to enhance trial design, biomarker development, and real-world evidence generation across multi
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflowsPR Newswire
- Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare diseasePR Newswire
- Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026PR Newswire
- Illumina Announces Changes to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Illumina Announces Changes to Board of DirectorsPR Newswire
ILMN
Earnings
- 2/5/26 - Beat
ILMN
Sec Filings
- 4/9/26 - Form ARS
- 4/9/26 - Form DEFA14A
- 4/9/26 - Form DEF
- ILMN's page on the SEC website